Implementing the generalized pustular psoriasis (GPP) Charter Implementing the generalized pustular psoriasis (GPP) Charter Read more about the projects are implementing the generalized pustular psoriasis (GPP) Charter
Closing healthcare gaps with continued vaccination campaigns Closing healthcare gaps with continued vaccination campaigns How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya.
Every Drop Counts – Water Stewardship at Boehringer Ingelheim Every Drop Counts – Water Stewardship at Boehringer Ingelheim How we work actively to protect clean water and reduce our water footprint in all communities where we operate
All hands-on deck to fight the ‘zombie’ rabies virus All hands-on deck to fight the ‘zombie’ rabies virus We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
Ethical Business Practices Ethical Business Practices Suppliers shall conduct their business in an ethical manner and act with integrity.
Rabies? Not in Mexico! Rabies? Not in Mexico! Mexico has been a rabies-free country for the last five years. How does Mexico achieve this? Learn how we're collaborating in this fight against rabies.
Boehringer Ingelheim good 2021 business performance Boehringer Ingelheim good 2021 business performance 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim.
Boehringer founding sponsor of CKM Health Initiative Boehringer founding sponsor of CKM Health Initiative Boehringer Ingelheim founding sponsor of AHA's Cardiovascular-Kidney-Metabolic Health Initiative
RE-LY-trial-publication-10-year-anniversary RE-LY-trial-publication-10-year-anniversary Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
International Women's Day International Women's Day We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”
New partnership to develop schizophrenia treatments New partnership to develop schizophrenia treatments Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments